David Favre

David Favre

Company: InnoSkel

Job title: CSO

Seminars:

PANEL DISCUSSION: Choosing Appropriate Delivery Methods for Successful Translation 11:30 am

Different delivery methods in different animal models impact translatability Setting up for long-term program success, including patient input Comparing between different animal models and capturing data effectivelyRead more

day: Post-Conference Discussion Day - Track B

Development of Lentiviral Vectors for Gene Therapy in Skeletal Dysplasia 11:00 am

InnoSkel focuses on gene therapy for inherited skeletal dysplasia Type II collagenopathies (COL2A1 deficiency), such as Spondyloepiphyseal Dysplasia congenita (SEDc) and related, are rare pediatric disease indications with unmet medical needs Systemic delivery of lentiviral vectors (LVV) can efficiently transduce cartilage cells in growth plates of juvenile SEDc disease mouse model and rescue the severe…Read more

day: Post-Conference Discussion Day - Track B

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.